PRKAA1 and cystic fibrosis: The discovery that S1P/AMPK signaling shuts down the CFTRΔF508 channels that reside at the cell surface has significant clinical ramifications, given that most the prevalent form of cystic fibrosis is caused by the ΔF508 mutation.